Elusys awarded $50.2 million for anthrax treatment

Written by Bryan Cohen (BioPrepWatch) on 04 August 2012.

Elusys Therapeutics, a biopharmaceutical company, announced this week that it has received additional funding from the US government for the development of an investigational agent for treating anthrax.

Full story here.